Umm AlQura University, 
Makah
KSA						                            
                            
						
 Review Article
												Conventional and Promising Biomarkers for Prostate Cancer their Clinical Implication and Prospective Role 						
Author(s): Hala FM Kamel and Anmar M NassirHala FM Kamel and Anmar M Nassir             
						
												
				 Prostate cancer (PCa) is one of the most common cancer in men and most common causes of male cancerrelated deaths. Over many years, biomarkers have been extensively studied for screening, diagnosis, prediction of (PCa) behavior and outcome and for assigning the patients during treatments. Molecular biomarkers could also help scientists to attain better understanding for the molecular basis of the disease and prediction of the patient response to therapies. Early detection of PCa was made possible about 30 years ago by the introduction of prostate specific antigen (PSA) in the clinical practice. However, PCa screening remains controversial, because of the risk of over diagnosis and/or over treatment and the inability to detect a significant proportion of advanced tumors. Several novel biomarkers have shown promises in preliminary studies. This review will f.. Read More»
				  
												DOI:
												 10.4172/2155-9929.1000262 
																	  
Journal of Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report